Home/Filings/4/0001213900-23-088909

4//SEC Filing

Vivo Capital Fund VIII, L.P. 4

Accession 0001213900-23-088909

CIK 0001641281other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 9:09 PM ET

Size

32.4 KB

Accession

0001213900-23-088909

Insider Transaction Report

Form 4

Period: 2023-11-16

Bolt Biotherapeutics, Inc.BOLT

Vivo Capital VIII, LLC

10% Owner

Transactions

Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Vivo Capital Fund VIII, L.P.

10% Owner

Transactions

Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Vivo Capital Surplus Fund VIII, L.P.

10% Owner

Transactions

Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Vivo Panda, LLC

10% Owner

Transactions

Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Vivo Opportunity, LLC

10% Owner

Transactions

Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Vivo Opportunity Fund Holdings, L.P.

10% Owner

Transactions

Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Vivo Panda Fund, L.P.

10% Owner

Transactions

Sale
Common Stock
2023-11-16$0.96/sh−6,429$6,172→ 143,571 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−7,531$7,230→ 1,989,685 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Comon Stock
2023-11-17$0.93/sh−8,211$7,636→ 1,981,474 total(indirect: By: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−27,465$25,268→ 1,954,009 total(indirect: Vivo Capital Fund VIII, L.P.)
Sale
Common Stock
2023-11-16$0.96/sh−1,040$998→ 274,749 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−1,134$1,055→ 273,615 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−3,792$3,489→ 269,823 total(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Sale
Common Stock
2023-11-20$0.92/sh−23,443$21,568→ 113,119 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)
Sale
Common Stock
2023-11-17$0.93/sh−7,009$6,518→ 136,562 total(indirect: By: Vivo Opportunity Fund Holdings, L.P.)

Holdings

Common Stock
(indirect: By: Vivo Panda Fund, L.P.)
1,448,286

Footnotes (6)

[F1]The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
[F2]The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
[F3]The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
[F4]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.95 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4
[F5]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.93 to $0.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (5) to this Form 4.
[F6]The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.92 to $0.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (6) to this Form 4.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Bolt Biotherapeutics, Inc.

CIK 0001641281

→

Entity typeother

Related Parties

filerCIK 0001618788

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 9:09 PM ET
Size: 32.4 KB

View on SEC.gov